Nuformix plc (LON:NFX – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.06 ($0.00), with a volume of 3374588 shares. The stock had previously closed at GBX 0.06 ($0.00).
Nuformix Stock Down 4.8 %
The business’s 50 day simple moving average is GBX 0.11 and its 200 day simple moving average is GBX 0.16. The company has a market capitalization of £491,586.00, a PE ratio of -1.63 and a beta of 1.22. The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Articles
- Five stocks we like better than Nuformix
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Dividend Capture Strategy: What You Need to Know
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
